Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.1M Buy
440,315
+3,246
+0.7% +$357K 2.06% 15
2026
Q1
$45.9M Buy
437,069
+57,294
+15% +$6.73M 2.39% 13
2025
Q4
$47.4M Buy
379,775
+4,420
+1% +$527K 2.77% 8
2025
Q3
$45M Sell
375,355
-47,177
-11% -$4.98M 2.97% 9
2025
Q2
$38.8M Buy
422,532
+58,665
+16% +$5.35M 2.83% 10
2025
Q1
$33.7M Sell
363,867
-2,497
-0.7% -$246K 3.05% 10
2024
Q4
$33.9M Buy
366,364
+7,922
+2% +$762K 3.05% 10
2024
Q3
$33.2M Buy
358,442
+4,680
+1% +$393K 2.98% 10
2024
Q2
$26.5M Buy
353,762
+3,408
+1% +$272K 2.54% 11
2024
Q1
$30.2M Buy
350,354
+182,207
+108% +$13.9M 3.01% 11
2023
Q4
$11.6M Buy
+168,147
New +$10.1M 1.29% 26

Other funds holding CRH

ARS Investment Partners's CRH Position: Q2 2026 in Review

ARS Investment Partners increased its CRH (CRH) stake by 0.74% in Q2 2026, buying an estimated $357K and bringing the position to 440,315 shares worth $47.1M. The position accounts for 2.06% of the portfolio, ranked #15.

ARS Investment Partners first reported a position in CRH in Q4 2023 and has held it in 11 quarters since. The position peaked at $47.4M in Q4 2025. 209 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • ARS Investment Partners held 440,315 shares of CRH worth $47.1M as of Q2 2026.
  • ARS Investment Partners bought 3,246 CRH shares in Q2 2026, an estimated $357K.
  • CRH made up 2.06% of ARS Investment Partners's portfolio in Q2 2026, its #15 holding.
  • ARS Investment Partners first reported a position in CRH in Q4 2023 and has held it in 11 quarters since.
  • ARS Investment Partners's CRH position peaked at $47.4M in Q4 2025.
  • 209 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on ARS Investment Partners's 13F filing for Q2 2026, filed 9 Jul 2026.